News Update
2019
- November 2019 – Back To Work And Off Disability After Resolution Of Total Knee Replacement Pain
- October 2019 – Regenesis Biomedical Named Arizona Bioscience Company Of The Year
- September 2019 – September is Pain Awareness Month
- August 2019 – Military Veteran’s Improved Quality of Life with Provant® Therapy
- July 2019 – Korea War Veteran’s Back Pain Relief With Provant® Therapy
- June 2019 – Summiting Mountains Of Rock And Mountains Of Pain: Leif Whittaker’s Story
- May 2019 – The Serenity Club: Recovery From Addiction
- April 2019 – A Navy Electronics Technician’s Relief from Chronic Pain
- March 2019 – A Marine Corps Sergeant’s Experience After Spine Surgery
- February 2019 – Regenesis Biomedical Has Patient Care Coordinators Who Track Patient Outcomes, Ensuring Appropriate Prescribing
- January 2019 – Physical Function And Emotional Well-Being Are Key To Getting Patients Back To Their Lives
2018
-
-
-
- December 2018 – Persistent Pain Impacts 100 Million U.S. Adults And Costs $500+ Billion Annually
- November 2018 – Pain Relief Or The Therapy Is Free
- October 2018 – Opioid Abuse In The Veteran’s Administration Population Translates To A Significant Economic Burden
- September 2018 – September Is Pain Awareness Month
- August 2018 – Reduction Of Pain-Causing Inflammation In Post-Operative Lumbar Patients
- July 2018 – Non-Drug Pain Relief Proven In A Clinical Trial
- June 2018 – Prevention Is A Key, By Managing Pain With A Range Of Treatments
- May 2018 – For Advanced Pain Relief, Energetics Matter
- April 2018 – In A Randomized Controlled Trial, Provant® Therapy Resulted In A Clinically Meaningful Reduction In Back Pain
- March 2018 – Pain Is More Common Than Diabetes, Heart Disease, & Cancer Combined
- February 2018 – The Opioid Crisis Has An Economic Cost Of Over $500 Billion Annually
- January 2018 – Successful Management Of Post-Op Neuropathic Pain Remains Elusive
- December 2018 – Persistent Pain Impacts 100 Million U.S. Adults And Costs $500+ Billion Annually
2017
-
-
-
- December 2017 – The 21st Century Cures Act Is Gaining Momentum
- November 2017 – Pulsed Electromagnetic Field Therapy Considered A “Must-Have Device”
- October 2017 – We Continue To Learn More About How Provant® Therapy Affects Pain Pathways
- September 2017 – Opioid Misuse Largely A Prescription-Related Problem
- August 2017 – Are You Attending PAINWEEK In September?
- July 2017 – Veterans’ Opioid Use Similar To U.S. Population
- June 2017 – Opioid Abuse Increasing Death Rates Nationwide
- May 2017 – For Advanced Pain Relief, Energetics Matter
- April 2017 – Knee Arthroscopy Improved Range of Motion and Pain Reduction
- March 2017 – Are You Reducing Patient Use Of Opioids?
- February 2017 – Why Choose Provant?
- January 2017 – Back Pain RCT Results
-
-
2016
-
-
-
-
- December 2016 – Depression With Back Pain
- November 2016 – Opioid Alternatives
- October 2016 – Keep Up With The Latest News
- September 2016 – Dangers Of Opioids
- August 2016 – Opioids Might Worsen Pain
- July 2016 – 15 Patient Case Series
- June 2016 – Return To Work Sooner
- May 2016 – Pain Medicine Reduction
- April 2016 – Pain Medicine Reduction
- March 2016 – Patient Satisfaction Survey
- Feburary 2016 – A Milestone In Pain Management
- January 2016 – Provant Therapy Improved 10 Pain Syndromes
-
-
-
2015
-
-
-
-
- December 2015 – Syndromes Improved with Provant
- November 2015 – Reduced Pain
- October 2015 – Resources for You
- September 2015 – Get the Most Out of Pain Management
- August 2015 – Reduce the Use of Pain Medications
- July 2015 – A Pain Management Milestone
- June 2015 – Potential Cost Savings
- May 2015 – Opioid Therapy Tool
- April 2015 – Resolution of Pain
- March 2015 – Resolution of Inflammation After Surgery
- February 2015 – Electromagnetic Energy
- January 2015 – Provant Therapy Clinical Trial
-
-
-
2014
-
-
- December 2014 – Avoid Additional Procedures and Costs
- November 2014 – Non-narcotic Alternative
- October 2014 – Post-Op Pain Relief
- September 2014 – Prompt Delivery of Pain Relief Therapy
- August 2014 – Pain Relief Clinical Study Results
- July 2014 – Proper Uses of the Provant Therapy System
- June 2014 – Inflammation Resolution
- May 2014 – Increased Endogenous Opioid Expression
- April 2014 – Regulation of Cytokine and Edema-related genes
- March 2014 – Changes in Cellular Membrane
- February 2014 – Mediating Agents
- January 2014 – FDA Clears Provant Therapy System
-
-
-